Rocket Lab Corporation heads into its August 6 earnings print with short sellers still adding exposure, options traders leaning bullish relative to recent norms, and the stock down 35% over the past month — a setup where the borrow market and the price chart are telling the same bearish story, but options are quietly pushing back.
Short interest has continued its relentless climb. It now represents nearly 9% of the free float — up another 4.7% on the week and 50% higher than it was six weeks ago. At the start of June, shorts held roughly 5.7% of float; today they hold 9%. That is a sustained, deliberate build, not a spike. The pace has accelerated: short interest added roughly 4 million shares in just the past two weeks after grinding steadily higher through June. The borrow market, however, offers no squeeze fuel. Availability is ample at 312%, meaning roughly three shares remain available for every one already borrowed — well above the tight threshold. Cost to borrow is running at just 0.37%, its lowest level in more than a month and down 29% on the week. Shorts can add at almost no friction cost.
Options positioning cuts against the bearish grain. The put/call ratio is running below its 20-day average — at 0.69 versus a mean of 0.73 — and is now 1.4 standard deviations below that average. That makes this the most call-heavy options tape has seen in some time, and notably different from what you might expect given the stock's trajectory. The 52-week PCR range runs from 0.36 to 0.85, so the current reading is not extreme on a full-year view, but the divergence from the recent trend is real. Options buyers appear to be positioning for a bounce or a catalyst rather than hedging further downside — an implicit vote that the $69 level is closer to floor than ceiling, at least for now.
The macro context for that optimism is Rocket Lab's recently announced Iridium acquisition, flagged in ORTEX's own intelligence notes. The deal gives the company a commercial revenue base beyond government contracts — the core bear concern for years. Whether it reshapes the financial story meaningfully enough to matter at August 6's print is the live question. The earnings history gives some context, though it cuts in both directions: the three most recent quarterly prints produced a -1.5% next-day move, +11.5%, and +24.6% respectively. A five-day window after those events showed gains of 18%, 24%, and 57%. The stock has rewarded buyers after results before — but the setup entering those prints was not one where short interest had just doubled in six weeks.
The ORTEX short score has climbed steadily to 52.7 from 47.2 on July 8, a two-week move that confirms the building short pressure is showing up in the composite signal. Peers have not fared much better on the week: LUNR fell 1.8%, VOYG dropped 9.5%, and RDW slid 3.3% — suggesting the sector-wide bid has softened. HOVR was the exception, surging 15% on the week, though on a much smaller base. The consistency of the peer weakness corroborates the view that RKLB's month-long decline is partly a sector story, not purely a company-specific one.
August 6 is the fulcrum. Short interest is at a multi-month high, borrow remains frictionless, and the Iridium deal adds a new variable that the market has not yet fully priced through a full quarterly reporting cycle — making the print less about near-term revenue beats and more about whether management can articulate a credible path to profitability with a larger, more complex business attached.
See the live data behind this article on ORTEX.
Open RKLB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
